Last update: June 10, 2018
Mild risk possible. Follow up recommended.
Read the Comment.
A drug to which the ability to reduce capillary permeability is attributed. Used to treat diabetic retinopathy and hemorrhoids.
Administered orally in two daily doses.
Since the last update we have not found published data on its excretion in breastmilk, although the manufacturer indicates negligible excretion in breastmilk (OMPharma 2018, AEMPS 2017).
As there is less published information than for other drugs from the same group, safer known alternatives may be preferable during the neonatal period and in case of prematurity.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM